跳至主要内容
临床试验/NCT06966856
NCT06966856尚未招募3 期

Sublingual Versus Oral Vitamin B12 for Acute Hypovitaminosis B12 Secondary to Proton Pump Inhibitors: A Prospective Randomized Study

Tanta University0 个研究点目标入组 23 人开始时间: 2026年12月30日最近更新:
干预措施
相关药物

试验速览

阶段
3 期
状态
尚未招募
入组人数
23
主要终点
Change in Serum Vitamin B12 Concentration

研究概览

简要总结

This randomized, clinical trial evaluates the efficacy of oral versus sublingual vitamin B12 supplementation in correcting early-onset vitamin B12 deficiency in adult patients using proton pump inhibitors (PPIs). The primary outcome is the change in serum vitamin B12 levels over a 6-week treatment period. Secondary outcomes include changes in homocysteine levels, hemoglobin levels, and patient-reported satisfaction.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • PPI use for 1-6 months (new users).
  • Serum B12 between 150-300 pg/mL.
  • No known prior B12 supplementation.

排除标准

  • History of long-term GI disease (e.g., Crohn's, celiac).
  • Previous gastrectomy/bariatric surgery.
  • Baseline anemia with hemoglobin <9 g/dL.
  • Severe renal or liver failure.

研究组 & 干预措施

Oral Vitamin B12 Group

Experimental

Participants in this arm will receive 1000 mcg oral cyanocobalamin daily for 6 weeks. The supplement will be administered as a swallowed tablet. Patients will continue their regular PPI therapy during the study period.

干预措施: Cyanocobalamin 1000 Mcg Oral Tablet (Drug)

Sublingual Vitamin B12 Group

Experimental

Participants in this arm will receive 1000 mcg sublingual cyanocobalamin daily for 6 weeks. The supplement will be administered as a sublingual tablet placed under the tongue. Patients will continue their regular PPI therapy during the study period.

干预措施: Cyanocobalamin 1000 Mcg Sublingual Tablet (Drug)

Control Group (PPI Only)

Active Comparator

Participants in this arm will continue their regular PPI therapy without receiving vitamin B12 supplementation. This arm serves as a control to evaluate natural changes in B12 levels without supplementation.

干预措施: Proton Pump Inhibitor therapy only (Other)

结局指标

主要结局

Change in Serum Vitamin B12 Concentration

时间窗: Baseline and Week 6

Measurement of serum vitamin B12 levels before and after 6 weeks of intervention to assess the efficacy of oral versus sublingual supplementation.

次要结局

  • Change in Hemoglobin Level(Baseline and Week 6)
  • Change in Plasma Homocysteine Level(Baseline and Week 6)
  • Patient-Reported Satisfaction with Route of Supplementation(Week 6)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Reem Alaa Abdel Samie

teacher assistant in Delta University for science and technology

Tanta University

相似试验